Anticoagulation in Cancer Related Stroke "OASIS-CANCER"

Recruiting

Phase N/A Results N/A

Summary of Purpose

Purpose: Cancer associated intravascular coagulopathy is the primary mechanism of cancer-related stroke, particularly in those without conventional stroke etiologies. Randomized clinical trials have investigated efficacy of vitamin K-dependent oral anticoagulant (warfarin), low-molecular-weight heparin (LMWH) and non-vitamin K-dependent oral anticoagulant (NOAC) for the prevention of systematic venous...

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 18 April 2016.

1 Oct 2009 10 Mar 2016 1 Dec 2018 1 Dec 2018 1 Mar 2016 Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Basics

Interventions

Conditions

Sponsors

Trial Design

  • Observation: Cohort
  • Perspective: Prospective
  • Sampling: Non-Probability Sample

Contacts